Takeheart Health Check      

252 Renaud S, de Longeril M.
Wine, alcohol, platelets and the French paradox for coronary heart disease.
Lancet 1992; 339: 1523-1526

253* Partridge MR.
Smoking and the young. A blot on the health of the nation.
BMJ 1992; 305: 2

254* English Life Tables No 14 1980-82
Also Interim Life Tables 1987-89

255* Brazier JE, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L.
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
BMJ 1992; 305: 160-164

256* Taylor V, Robson J, Evans S.
Risk factors for coronary heart disease: a study in inner London
Br Journ Gen Prac 1992; 42: 377-380

257* Koperski M.
Systematic care of diabetic patients in one general practice: how much does it cost?
Br Journ Gen Prac 1992; 42: 370-372

258* Dewar JA, Horobin JM, Preece PE, Tavendale R, Tunstall-Pedoe H, Wood RAB.
Long term effects of tamoxifen on blood lipid values in breast cancer.
BMJ 1992; 305: 225-226

259* Sing RB, Niaz MA.
Diets that protect against coronary heart disease.
BMJ 1992; 305: 473

260* Randall A, Muir J, Mant D.
Value of Dundee coronary risk-disk.
BMJ 1992; 305: 473

261 Lennox AS.
Determinants of outcome in smoking cessation.
Br J Gen Pract 1992; 42: 247-252

262 J Roy Soc Med 1992; 85: 478-482

263 Turnbull.W et alia
Review article JAMA 24/6/92 3317-3325

264* Heather Kirby
A Survivor's tips on survival
The Times 12/2/93 p15
Sir Richard Doll, in his 81st year.

265* Bullock D.
Quality Assurnace for Testing in Primary Care
Royal College of General Practitioners, Connections Feb 1993 p2-3

266* Kelly MP, Charlton B.
Health promotion: time for a new philosophy?
Br J Gen Pract 1992; 42: 223-224 (editorial)

267* Charlton B, Kelly MP.
Paying for an off the peg life: positive health, like any other comodity, is subject to fashion.
Times Higher Educ Suppl 1992; 22 May: 19

268 Kelly MP, Sullivan F.
The productive use of threat in primary care: behavioural responses to health promotion.
Fam Pract 1993

269* Davison C, Frankel S, Smith GD.
The limits of lifestyle: reassessing "fatalism" in the popular culture of illness prevention.
Soc Sci Med 1992; 34: 675-685

270* Charlton Bruce, Kelly Michael.
Health promotion: time for a new philosophy?
Br J Gen Pract 1993; 43: 85-86 (letter)

271* OXCHECK Study Group
Prevalence of risk factors for heart disease in OXCHECK trial: Implications for screening in primary care.
BMJ 1991; 302: 1057-1060

272 Ramsay LE, Yeo WW, Jackson PR.
Dietary reduction of serum cholesterol concentration: time to think again.
BMJ 1992; 303: 953-957

273 Knutsen SR, Knutsen R.
The Tromso Survey: the family intervention study - the effect of intervention on some coronary risk factors and dietary habits, a 6 year follow up.
Prev Med 1991; 20: 197-212

274 Bolton-Smith C, Woodward M, Smith WCS, Tunstall-Pedoe H.
Dietary and non-dietary predictors of serum total and high density lipid cholesterol in men and women: results from the Scottish heart health study.
Int J Epidemiol 1991; 20: 95-104

275 Jacobs D, Blackburn H, Higgins M et alia.
Report of the conference on low blood cholesterol; mortality associations.
Circulation 1992; 86: 1046-1060

276* Information Booklet
Cholesterol Screening in Community Pharmacies
National Pharmaceutical Association Feb 1993

277* Report on European Atherosclerosis Society launch of guidelines. Professor Yechezkiel Stein quoted
Scrip 1992; 1779: 19 also Doctor 25/3/93 p30

278 News Item
BMJ 1993; 306: 478-9

279 Hulley SB.
Cholesterol screening not recommended in young adults
JAMA 17/3/93

280 Cooper SJ, Cocksedge SH.
Cholesterol Screening [letter]
Br J Gen Pract 1992; 42: 260-261

281 Tunstall-Pedoe H
The Dundee coronary risk-disk for management of change in risk factors.
BMJ 1991; 303: 744-747

282 Working group of the Coronary Prevention Group and the British Heart Foundation. An action plan for preventing coronary heart disease in prinary care
BMJ 1991; 303: 748-750

283 Lewis B, Chait A, Wootton IDP, et alia
Fequency of risk factors for ischaemic heart disease in a healthy British population.
Lancet 1974; 1: 141-146

284 Rink E, Hilton S, Szczepura A, Fletcher J, Sibbald B, Davies C, et alia.
The impact of introducing near patient testing for standard investigations in general practice.
BMJ 1993; 307: 775-8

285 Miller WG, McKenney JM, Conner MR, Chinchilli VM.
Total error assessment of five methods for cholesterol screening.
Clin Chem 1993; 39: 297-304

286* Skrabanek P.
"Health Policing" erodes civil liberties.
The Practitioner 1992; 236: 989-990

287* Bellew W.
Preventive medicine is good for your health.
The Practitioner 1992; 236: 989-990

288 Stensvold I, Tverdal A, Urdal P, Graff-Iverson S.
BMJ 1993; 307: 1318-1322

289* Guidelines for Implementation of Near-patient Testing
Association of Clinical Biochemists September 1993

290* Chapman S.
The role of doctors in promoting smoking cessation.
BMJ 1993; 307: 518-519

291 Rosalki SB, Rav D, Lehman D, Prentice M.
The determination of serum gamma-glutamyl-transpeptidase activity and its clinical applications.
Aner Journ Clin Biochem 1970; 7: 143-7

292 Chick J, Lloyd G, Crombie E.
Counselling problem drinkers in medical wards: a controlled study.
BMJ 1985; 290: 965-7

293 Dunbar JA, Oston SA, Ritchie A, Delgun MS, Haggart J, Martin BT.
Are problem drinkers dangerous drivers?
BMJ 1985; 290: 827-30

294 Royal College of Physicians
A great and growing evil: the medical consequences of alcohol abuse.
Tavistock, London 1987.

295* Wald NJ, Law M,Watt HC, Wu T, Bailey A, Johnson AM, Craig WY, Ledue TB, Haddow JE.
Apolipoproteins and ischaemic heart disease: implications for screening.
Lancet 1994; 343: 75-79

296* Leng GC, Fowkes FGR.
Does lipid-lowering therapy promote regression of coronary atheroma?
Brit Journ Gen Prac 1994; January: 3-4

297* Diagnostics Business-Matters and Pharmaceutical Company News
No 69 Jan 1994 8-10

298* Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A.
Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.
BMJ 1994; 308: 363-366

299* Law MR, Wald NJ, Thompson SG.
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
BMJ 1994; 308: 367-372

300* Law MR, Thompson SG, Wald NJ.
Assessing possible hazards of reducing serum cholesterol.
BMJ 1994; 308: 373-379